Skip to main content
CivicGate

SB 77 KY
Became Law

AN ACT relating to ibogaine research in the Commonwealth.

KY · session 2026RS · Senate · bill

A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →

Introduced Jan 13, 2026

Latest action (Apr 14, 2026) delivered to Secretary of State (Acts Ch. 158)

Summary

Create new sections of KRS Chapter 218A to define terms; establish the ibogaine research and intellectual property fund to be administered by the Department of Agriculture for the purpose of allowing the department to enter a public-private partnership with a drug developer to conduct a clinical drug development trial or trials related to the use of ibogaine for the treatment of opioid use disorder, co-occurring substance use disorder, or any other neurological or mental health condition for which ibogaine demonstrates efficacy; establish requirements for the department related to how it contracts with a drug developer related to ibogaine research and intellectual property; appropriate $21 million from the opioid abatement trust fund to the ibogaine research and intellectual property development fund in fiscal year 2026-2027 and in fiscal year 2027-2028; APPROPRIATION; EMERGENCY.

Sponsors (7)

Action history (35)

  1. Jan 13, 2026 introduced in Senate · upper
  2. Jan 13, 2026 to Committee on Committees (S) · upper
  3. Mar 9, 2026 to Health Services (S) · upper
  4. Mar 11, 2026 reported favorably, 1st reading, to Calendar with Committee Substitute (1) and Committee Amendment (1-title) · upper
  5. Mar 12, 2026 2nd reading, to Rules · upper
  6. Mar 12, 2026 posted for passage in the Regular Orders of the Day for Friday, March 13 2026 · upper
  7. Mar 13, 2026 3rd reading, passed 35-2 with Committee Substitute (1) and Committee Amendment (1-title) · upper
  8. Mar 17, 2026 received in House · lower
  9. Mar 17, 2026 to Committee on Committees (H) · lower
  10. Mar 20, 2026 to Veterans, Military Affairs, & Public Protection (H) · lower
  11. Mar 24, 2026 reported favorably, 1st reading, to Calendar · upper
  12. Mar 25, 2026 2nd reading, to Rules · upper
  13. Apr 1, 2026 taken from Rules · upper
  14. Apr 1, 2026 placed in the Orders of the Day · upper
  15. Apr 1, 2026 3rd reading, passed 82-8 · upper
  16. Apr 1, 2026 received in Senate · upper
  17. Apr 1, 2026 enrolled, signed by President of the Senate · upper
  18. Apr 1, 2026 enrolled, signed by Speaker of the House · lower
  19. Apr 1, 2026 delivered to Governor · upper
  20. Apr 13, 2026 Vetoed · upper
  21. Apr 14, 2026 received in Senate · upper
  22. Apr 14, 2026 to Rules (S) · upper
  23. Apr 14, 2026 posted for passage for consideration of Governor's veto · upper
  24. Apr 14, 2026 veto overridden · upper
  25. Apr 14, 2026 passed 31-6 · upper
  26. Apr 14, 2026 received in House · lower
  27. Apr 14, 2026 to Rules (H) · lower
  28. Apr 14, 2026 taken from Rules (H) · lower
  29. Apr 14, 2026 posted for consideration of Governor's veto · upper
  30. Apr 14, 2026 veto overridden · upper
  31. Apr 14, 2026 passed 77-18 · upper
  32. Apr 14, 2026 received in Senate · upper
  33. Apr 14, 2026 enrolled, signed by President of the Senate · upper
  34. Apr 14, 2026 enrolled, signed by Speaker of the House · lower
  35. Apr 14, 2026 delivered to Secretary of State (Acts Ch. 158) · upper
Subjects
AgricultureAppropriationsBudget And Financial AdministrationDrugs And MedicinesEffective Dates, EmergencyFundsOpioidsPublic HealthState Agencies

Full text

The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.

Comments

Comments

Loading comments…

Data from OpenStates. View on OpenStates →